Changes

Jump to: navigation, search

Avatrombopag (Doptelet)

434 bytes removed, 20:22, 3 December 2018
m
no edit summary
==Diseases for which it is used==
*[[Immune thrombocytopenia (ITP)]]
# Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [http://bloodjournal.hematologylibrary.org/content/123/25/3887.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24802775 PubMed]
*[[Thrombocytopenia in liver disease]]
==History of changes in FDA indication==
* 5/21/2018: FDA approved "for [[Thrombocytopenia in liver disease|thrombocytopenia in adults with chronic liver disease]] scheduled to undergo a procedure."
==Also known as==
LookupUsers, editors, emailconfirmed
23,527
edits

Navigation menu